The ac4C writer NAT10 has been implicated in promoting malignant behaviors across multiple cancer types by modulating the ac4C modifications of various mRNAs or proteins, and its expression is strongly associated with tumor aggressiveness and poor clinical outcomes (24). The gene discussed is NAT10; the disease is cancer.